Ligand-independent Activation of the Androgen Receptor by Interleukin-6 and the Role of Steroid Receptor Coactivator-1 in Prostate Cancer Cells*
暂无分享,去创建一个
Nicholas Bruchovsky | N. Bruchovsky | M. Sadar | T. Ueda | Takeshi Ueda | Nasrin R. Mawji | Marianne D. Sadar | N. Mawji | Takeshi Ueda
[1] H. Kung,et al. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[2] A. Belldegrun,et al. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. , 1995, Cancer research.
[3] G. Ciliberto,et al. Blocking signaling through the gp130 receptor chain by interleukin‐6 and oncostatin M inhibits PC‐3 cell growth and sensitizes the tumor cells to etoposide and cisplatin‐mediated cytotoxicity , 1999, Cancer.
[4] B. Katzenellenbogen,et al. Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. , 1991, Endocrinology.
[5] Tetsurou Matsumoto,et al. Different expression of androgen receptor coactivators in human prostate. , 2001, Urology.
[6] G. Coetzee,et al. Multiple Signal Input and Output Domains of the 160-Kilodalton Nuclear Receptor Coactivator Proteins , 1999, Molecular and Cellular Biology.
[7] H. Klocker,et al. Immunohistochemical localization of interleukin‐6 and its receptor in benign, premalignant and malignant prostate tissue , 2000, The Journal of pathology.
[8] P. Brodt,et al. Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. , 1992, Cancer research.
[9] E. Mulder,et al. Ligand-induced Conformational Alterations of the Androgen Receptor Analyzed by Limited Trypsinization , 1995, The Journal of Biological Chemistry.
[10] L. Nazareth,et al. Activation of the Human Androgen Receptor through a Protein Kinase A Signaling Pathway* , 1996, The Journal of Biological Chemistry.
[11] G. Jenster,et al. Identification of Two Transcription Activation Units in the N-terminal Domain of the Human Androgen Receptor (*) , 1995, The Journal of Biological Chemistry.
[12] H. Klocker,et al. Distant metastases from prostatic carcinoma express androgen receptor protein. , 1995, Cancer research.
[13] C. Robson,et al. Tip60 Is a Nuclear Hormone Receptor Coactivator* , 1999, The Journal of Biological Chemistry.
[14] F. S. French,et al. Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. , 1976, The Journal of biological chemistry.
[15] J. Gustafsson,et al. Structural determinants of DNA-binding specificity by steroid receptors. , 1995, Molecular endocrinology.
[16] T. H. van der Kwast,et al. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. , 1991, Molecular endocrinology.
[17] M. Sadar,et al. Phenobarbital Induction of CYP1A1 Gene Expression in a Primary Culture of Rainbow Trout Hepatocytes* , 1996, The Journal of Biological Chemistry.
[18] R. Oyasu,et al. Autocrine effect of androgen on proliferation of an androgen responsive prostatic carcinoma cell line, LNCAP: role of interleukin-6. , 1997, Endocrinology.
[19] H. Frierson,et al. Activation of mitogen-activated protein kinase associated with prostate cancer progression. , 1999, Cancer research.
[20] F. Claessens,et al. The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1 , 1999, Molecular and Cellular Biology.
[21] D. W. Waring,et al. Activation of the progesterone receptor by the gonadotropin-releasing hormone self-priming signaling pathway. , 1994, Molecular endocrinology.
[22] K. Korach,et al. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. , 1993, Molecular endocrinology.
[23] R. Miesfeld,et al. Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation. , 1990, Molecular endocrinology.
[24] J. Trapman,et al. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. , 1997, Molecular endocrinology.
[25] U. Pagotto,et al. The unliganded estrogen receptor (ER) transduces growth factor signals , 1994, The Journal of Steroid Biochemistry and Molecular Biology.
[26] N. Bruchovsky,et al. Prostate cancer: molecular biology of early progression to androgen independence. , 1999, Endocrine-related cancer.
[27] N. Weigel,et al. 8-Bromo-Cyclic AMP Induces Phosphorylation of Two Sites in SRC-1 That Facilitate Ligand-Independent Activation of the Chicken Progesterone Receptor and Are Critical for Functional Cooperation between SRC-1 and CREB Binding Protein , 2000, Molecular and Cellular Biology.
[28] M. T. Abreu-Martin,et al. Mitogen-Activated Protein Kinase Kinase Kinase 1 Activates Androgen Receptor-Dependent Transcription and Apoptosis in Prostate Cancer , 1999, Molecular and Cellular Biology.
[29] B. O’Malley,et al. Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.
[30] F. S. French,et al. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. , 2001, Cancer research.
[31] T. Willson,et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.
[32] I. Pastan,et al. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. , 1990, Cancer research.
[33] Desok Kim,et al. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. , 1998, Cancer research.
[34] F. S. French,et al. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. , 1995, Molecular endocrinology.
[35] C. Logothetis,et al. Clinical significance of elevation in neuroendocrine factors and interleukin-6 in metastatic prostate cancer. , 1995, Urologic oncology.
[36] R. Matusik,et al. Induction of cell-free, in vitro transcription by recombinant androgen receptor peptides , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[37] J. Simons,et al. Interleukin-6: a candidate mediator of human prostate cancer morbidity. , 1995, Urology.
[38] J. Simons,et al. Characterization of the role of IL‐6 in the progression of prostate cancer , 1999, The Prostate.
[39] H. Klocker,et al. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. , 1998, Cancer research.
[40] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[41] N. Bruchovsky,et al. Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways* , 2002, The Journal of Biological Chemistry.
[42] R J Fletterick,et al. Structure and specificity of nuclear receptor-coactivator interactions. , 1998, Genes & development.
[43] M. Kattan,et al. Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. , 1999, The Journal of urology.
[44] D. Tweardy,et al. Interleukin‐6 induces prostate cancer cell growth accompanied by activation of Stat3 signaling pathway , 2000, The Prostate.
[45] Helmut Klocker,et al. Rapid signalling by androgen receptor in prostate cancer cells , 1999, Oncogene.
[46] B. He,et al. Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 Coactivator Recruitment by Activation Function 2* , 2001, The Journal of Biological Chemistry.
[47] G. Murphy,et al. Circulating levels of interleukin‐6 in patients with hormone refractory prostate cancer , 1999, The Prostate.
[48] Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. , 1993, Molecular endocrinology.
[49] J. Lees,et al. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.
[50] F. S. French,et al. Transcriptional activation and nuclear targeting signals of the human androgen receptor. , 1991, The Journal of biological chemistry.
[51] H. Klocker,et al. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. , 1995, European urology.
[52] M. Sadar. Androgen-independent Induction of Prostate-specific Antigen Gene Expression via Cross-talk between the Androgen Receptor and Protein Kinase A Signal Transduction Pathways* , 1999, The Journal of Biological Chemistry.
[53] W. Catalona,et al. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. , 1993, JAMA.